Essential fatty acids: Food for mind and body

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue 8, 2012, Pages 808-810

  Forbes, David ^a   Parsons, Howard ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID;

ANOREXIA NERVOSA; ATTENTION DEFICIT DISORDER; AUTISM; ESSENTIAL FATTY ACID DEFICIENCY; HUMAN; MALNUTRITION; NOTE; NUTRITIONAL STATUS; PRIORITY JOURNAL;

ANOREXIA NERVOSA; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; DIETARY FATS, UNSATURATED; DIETARY SUPPLEMENTS; FATTY ACIDS, ESSENTIAL; HUMANS; MALNUTRITION;

EID: 84863849405     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2012.02748.x     Document Type: Note

References (29)

1. Swenne I, Rosling A,. Omega-3 essential fatty acid status is improved during nutritional rehabilitation of adolescent girls with eating disorders and weight loss. Acta Paediatr 2012; 101: 858-61.
2. Bistrian BR,. Clinical aspects of essential fatty acid metabolism: Jonathan Rhoads Lecture. JPEN J Parenter Enteral Nutr 2003; 27: 168-75.
3. Uauy R, Dangour AD,. Fat and fatty acid requirements and recommendations for infants of 0-2 years and children of 2-18 years. Ann Nutr Metab 2009; 55: 76-96.
4. Hibbeln JR,. Depression, suicide and deficiencies of omega-3 essential fatty acids in modern diets. World Rev Nutr Diet 2009; 99: 17-30.
5. Dupont J, Amédée-Manesme O, Pepin D, Chambaz J,. Eicosanoid synthesis in children with cholestatic disease. J Inherit Metab Dis 1990; 13: 212-8.
6. Parsons HG, O'Loughlin EV, Forbes D, Cooper D, Gall DG,. Supplemental calories improve essential fatty acid deficiency in cystic fibrosis patients. Pediatr Res 1988; 24: 353-6.
7. Agostoni C, Giovannini M, Sala D, Usuelli M, Livio L, Francescato G, et al., Double-blind, placebo-controlled trial comparing effects of supplementation of two micronutrient sprinkles on fatty acid status in Cambodian infants. J Pediatr Gastroenterol Nutr 2007; 44: 136-42.
8. Swenne I, Rosling A, Tengblad S, Vessby B,. Essential fatty acid status in teenage girls with eating disorders and weight loss. Acta Paediatr 2011; 100: 762-7.
9. Innis SM,. Omega-3 fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations? J Pediatr Gastroenterol Nutr 2009; 48 (Suppl 1): S16-24.
10. Uauy R, Dangour AD,. Nutrition in brain development and aging: role of essential fatty acids. Nutr Rev 2006; 64 (5 Pt 2): S24-33; discussion S72-91.
11. Farquharson J, Cockburn F, Patrick WA, Jamieson EC, Logan RW,. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 1992; 340: 810-3.
12. Innis SM, Friesen RW,. Essential n-3 fatty acids in pregnant women and early visual acuity maturation in term infants. Am J Clin Nutr 2008; 87: 548-57.
13. Schulzke SM, Patole SK, Simmer K,. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2011; 2: CD000375.
14. Simmer K, Patole SK, Rao SC,. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2011; 12: CD000376.
15. Raz R, Gabis L,. Essential fatty acids and attention-deficit- hyperactivity disorder: a systematic review. Dev Med Child Neurol 2009; 51: 580-92.
16. Bell JG, Miller D, MacDonald DJ, MacKinlay EE, Dick JR, Cheseldine S, et al., The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intake. Br J Nutr 2010; 103: 1160-7.
17. James S, Montgomery P, Williams K,. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 2011; 11: CD007992.
18. Sublette ME, Hibbeln JR, Galfalvy H, Oquendo MA, Mann JJ,. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 2006; 163: 1100-2.
19. Sublette ME, Ellis SP, Geant AL, Mann JJ,. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011; 72: 1577-84.
20. Swenne I, Rosling A, Tengblad S, Vessby B,. Omega-3 polyunsaturated essential fatty acids are associated with depression in adolescents with eating disorders and weight loss. Acta Paediatr 2011; 100: 1610-5.
21. Sarris J, Mischoulon D, Schweitzer I,. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry 2012; 73: 81-6.
22. Barbarich NC, McConaha CW, Halmi KA, Gendall K, Sunday SR, Gaskill J, et al., Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa. Int J Eat Disord 2004; 35: 10-5.
23. Langan SM, Farrell PM,. Vitamin E, vitamin A and essential fatty acid status of patients hospitalized for anorexia nervosa. Am J Clin Nutr 1985; 41: 1054-60.
24. Holman RT, Adams CE, Nelson RA, Grater SJ, Jaskiewicz JA, Johnson SB, et al., Patients with anorexia nervosa demonstrate deficiencies of selected essential fatty acids, compensatory changes in nonessential fatty acids and decreased fluidity of plasma lipids. J Nutr 1995; 125: 901-7.
25. Ayton AK,. Dietary polyunsaturated fatty acids and anorexia nervosa: is there a link? Nutr Neurosci 2004; 7: 1-12.
26. Ratnayake WM, Galli C,. Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann Nutr Metab 2009; 55: 8-43.
27. Holman RT, Johnson SB, Mercuri O, Itarte HJ, Rodrigo MA, De Tomas ME,. Essential fatty acid deficiency in malnourished children. Am J Clin Nutr 1981; 34: 1534-9.
28. Dias VC, Parsons HG,. Modulation in delta 9, delta 6, and delta 5 fatty acid desaturase activity in the human intestinal CaCo-2 cell line. J Lipid Res 1995; 36: 552-63.
29. Caspar-Bauguil S, Montastier E, Galinon F, Frisch-Benarous D, Salvayre R, Ritz P,. Anorexia nervosa patients display a deficit in membrane long chain poly-unsaturated fatty acids. Clin Nutr 2012; 3: 386-90.